CorFlow Therapeutics is set to initiate a pivotal trial of its CorFlow CoFl system across US hospitals for heart attack.

The US FDA has approved Boston Scientific’s expanded instructions for use (IFU) labelling of the Farapulse Pulsed Field Ablation (PFA) System.

Miach Orthopaedics has completed the enrolment for the BEAR MOON study, which compares the collagen-based BEAR Implant.

Morphic Medical has obtained an EU CE mark for RESET, a device designed to target the underlying cause of obesity and type 2 diabetes (T2D).

US-based PanTher Therapeutics has initiated a trial of its chemotherapy-eluting patch, which it hopes will make cancer therapy more tolerable.

The Chinese Ministry for Commerce said the “EU has insisted on taking restrictive measures to build new protectionist barriers”.

Welsh startup Amotio has raised £810,000 ($1.1m) to advance its technology for improving outcomes during orthopaedic revision surgery.

USW researchers are set to develop biodegradable batteries that can be positioned in humans for powering medical implants.

Trinity College Dublin in Ireland has installed the BioBrillouin microscope to propel studies in cancer, inflammation, developmental biology.

A Karolinska Institutet-led study has demonstrated that the use of an AI tool can enhance skin cancer diagnosis.

Fresenius Medical Care (FME) has collaborated with Mexico's CCINSHAE to extend HighVolumeHDF access to individuals.

A court has approved the $305m sale of 23andMe’s assets to a nonprofit led by former 23andMe CEO Anne Wojcicki.